EXTON, Pa., Aug. 28 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the Thomas Weisel Partners 2008 Healthcare Conference at 8:00 A.M. ET on Thursday, September 4, 2008. The conference is being held at the Four Seasons Hotel in Boston, MA.
ViroPharma also announced that William Roberts, vice president, corporate communications of ViroPharma will present at the 15th Annual BioCentury Newsmakers in the Biotech Industry Conference at 1:30 P.M. ET on Thursday, September 4, 2008. The conference is being held at the Millennium Broadway Hotel in New York.
Mr. Roberts also will present at the UBS Global Life Sciences Conference at 8:00 A.M. ET on Tuesday, September 23, 2008. The conference is being held at the Grand Hyatt in New York.
ViroPharma's presentations will be webcast live for investors through http://www.viropharma.com and available for a period of 14 days following the conferences.
About ViroPharma Incorporated
ViroPharma Incorporated is committed to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R) approved for oral administration for treatment of antibiotic- associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/Products.aspx). ViroPharma currently focuses its drug development activities in infectious diseases including cytomegalovirus (CMV) and non-toxigenic C. difficile (NTCD). For more information on ViroPharma, visit the Company's website at http://www.viropharma.com.
|SOURCE ViroPharma Incorporated|
Copyright©2008 PR Newswire.
All rights reserved